Covered recipient · General Payments record
KENNETH RANDELL GROSSMAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,747.49
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.48 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.64 | 14 |
| Sight Sciences, Inc. | $89.40 | 4 |
| Alcon Laboratories Inc | $69.02 | 3 |
| Apellis Pharmaceuticals, Inc. | $67.21 | 3 |
| Alimera Sciences, Inc. | $35.67 | 2 |
| Bausch & Lomb Americas Inc. | $23.66 | 1 |
| Tarsus Pharmaceuticals, Inc. | $20.29 | 1 |
| Amgen Inc. | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.72 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843358 | CMS |
| ABBVIE INC. | $11.99 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843360 | CMS |
| ABBVIE INC. | $34.21 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843362 | CMS |
| ABBVIE INC. | $33.23 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843364 | CMS |
| ABBVIE INC. | $11.66 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843366 | CMS |
| ABBVIE INC. | $27.88 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843368 | CMS |
| ABBVIE INC. | $10.36 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843370 | CMS |
| ABBVIE INC. | $28.45 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843372 | CMS |
| ABBVIE INC. | $10.54 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843374 | CMS |
| ABBVIE INC. | $5.39 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843376 | CMS |
| ABBVIE INC. | $5.68 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843378 | CMS |
| ABBVIE INC. | $4.44 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843380 | CMS |
| ABBVIE INC. | $5.21 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843382 | CMS |
| ABBVIE INC. | $4.88 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103843384 | CMS |
| Alcon Vision LLC | $24.49 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110660443 | CMS |
| Alcon Vision LLC | $22.76 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110660441 | CMS |
| Alcon Vision LLC | $21.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110660439 | CMS |
| Alimera Sciences, Inc. | $19.77 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092829113 | CMS |
| Alimera Sciences, Inc. | $15.90 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092838150 | CMS |
| Amgen Inc. | $14.59 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590052 | CMS |
| Apellis Pharmaceuticals, Inc. | $25.36 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024497 | CMS |
| Apellis Pharmaceuticals, Inc. | $21.73 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024499 | CMS |
| Apellis Pharmaceuticals, Inc. | $20.12 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024501 | CMS |
| Bausch & Lomb Americas Inc. | $23.66 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140385946 | CMS |
| Sight Sciences, Inc. | $18.04 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151927805 | CMS |
| Sight Sciences, Inc. | $15.54 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151927803 | CMS |
| Sight Sciences, Inc. | $30.60 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151927809 | CMS |
| Sight Sciences, Inc. | $25.22 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151927807 | CMS |
| Tarsus Pharmaceuticals, Inc. | $20.29 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139100519 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.